Showing results (1531-1540 of 12,170) with videos related to
Sort By:
Pageof 1,217
Journal of Cardiovascular Pharmacology|January 1, 1989
Effects of norepinephrine and angiotensin II on plasma atrial natriuretic peptide concentration in humansK Shimamoto, M Nakagawa, S Fukuyama, et al.Journal of Cardiovascular Pharmacology|January 1, 1989
Functional atrial natriuretic peptide receptor in human adrenal tumorH Shionoiri, N Hirawa, I Takasaki, et al.Journal of Cardiovascular Pharmacology|March 14, 2014
Cryptotanshinone attenuates cardiac fibrosis via downregulation of COX-2, NOX-2, and NOX-4Yunzi Ma, Hong Li, Zhongbao Yue, et al.Journal of Cardiovascular Pharmacology|March 14, 2014
Effects of nimesulide, a selective COX-2 inhibitor, on cardiovascular function in 2 rat models of diabetesJoanne Y T Leung, Catherine C Y PangJournal of Cardiovascular Pharmacology|April 3, 2014
Lack of clinical pharmacodynamic and pharmacokinetic drug-drug interactions between warfarin and the antisense oligonucleotide mipomersenZhaoyang Li, Marjie L Hard, John S Grundy, et al.Journal of Cardiovascular Pharmacology|January 1, 1989
The sympathetic nervous system and converting enzyme inhibitionS G BallJournal of Cardiovascular Pharmacology|January 1, 1989
Effects on autonomic function of a new angiotensin converting enzyme inhibitor, ramiprilK Sugimoto, Y Kumagai, T Tateishi, et al.Journal of Cardiovascular Pharmacology|January 1, 1989
Pharmacokinetic and pharmacodynamic properties of ramipril in patients with congestive heart failure (NYHA III-IV)U Gerckens, E Grube, T Mengden, et al.Journal of Cardiovascular Pharmacology|January 1, 1989
Steady-state kinetics of ramipril in renal failureH Schunkert, J Kindler, M Gassmann, et al.Journal of Cardiovascular Pharmacology|March 4, 2021
Shexiang Baoxin Pill Attenuates Ischemic Injury by Promoting Angiogenesis by Activation of Aldehyde Dehydrogenase 2Jingjing Hu, Yongchao Zhao, Yonghui Wu, et al.Pageof 1,217